Loading
Latest filing published 21 Nov 2022 for Aerie Pharmaceuticals INC, €238k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
This profile gathers the share dealings of Michael du Toit in Aerie Pharmaceuticals Inc, where the filings describe the role as board member. Between 17 June 2021 and 21 November 2022, the trades on record add up to 3 filings.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The record was last updated on 21 November 2022 with a transaction (€238k) in Aerie Pharmaceuticals Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations